Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Mayfield Hts › NPI 1902858152
Hospital

Cleveland Clinic Health System - East Region

Cleveland Clinic Health System - East Region was paid $32.76M by Medicaid between Jan 2018 and Dec 2024, across 427 billing codes. Its largest line is 99283, emergency room visit (moderate) — 11% of everything it billed.

33Billing provider infoCLEVELAND CLINIC HEALTH SYSTEM - EAST REGION
MAYFIELD HTS, OH 44124
33aNPI1902858152assigned 05/16/2006
28Total paid$32.76M
24GClaims776,192
24DCodes billed427
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#36 of 101
Median peer was paid$22.32M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,684$876K
201923,374$1.06M
202015,668$975K
202134,797$1.94M
202253,970$2.92M
2023349,691$15.00M
2024incomplete273,008$9.99M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 27,925 25,678 $3.52M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 26,587 22,406 $3.48M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 11% 34,180 28,351 $3.45M
96361 Intravenous infusion, hydration; each additional hour 9.7% 9,309 6,050 $3.18M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6.3% 14,002 12,408 $2.06M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.9% 15,619 13,572 $1.92M
70450 Computed tomography, head or brain; without contrast material 3.0% 3,913 3,216 $987K
G0378 Hospital observation service, per hour 2.3% 10,255 4,406 $769K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.1% 3,128 2,583 $695K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 5,269 4,661 $618K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.7% 2,692 1,266 $544K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.6% 2,368 1,968 $536K
415 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 3,900 $527K
59025 Fetal non-stress test 1.5% 2,806 $487K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.4% 4,311 $464K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.2% 1,777 $387K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1.2% 3,468 $381K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,350 $309K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,233 $299K
80053 Comprehensive metabolic panel <1% 35,777 $239K
78815 Positron emission tomography (PET) for limited area imaging <1% 341 $220K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,795 $203K
96127 <1% 2,150 $197K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,533 $195K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,400 $190K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,212 $190K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,761 $186K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,030 $184K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 700 $179K
81513 <1% 1,177 $175K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 662 $169K
76770 <1% 929 $166K
87631 <1% 1,357 $157K
96161 <1% 1,164 $157K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,604 $152K
70498 <1% 459 $127K
90834 Psychotherapy session, about 45 minutes <1% 903 $125K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 1,024 $119K
93975 <1% 961 $117K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 686 $110K
90837 Psychotherapy session, about an hour <1% 742 $105K
71046 Radiologic examination, chest; 2 views <1% 6,679 $101K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 166 $88K
86850 <1% 3,751 $87K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 141 $84K
70491 <1% 247 $83K
70551 Magnetic resonance imaging, brain; without contrast material <1% 499 $82K
71250 <1% 912 $77K
0002A <1% 2,047 $77K
82805 <1% 2,304 $76K
0001A <1% 2,099 $75K
92551 <1% 1,252 $75K
96367 <1% 1,167 $73K
80048 Basic metabolic panel (calcium, ionized) <1% 10,040 $73K
90791 Psychiatric diagnostic evaluation <1% 364 $73K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 35,972 $72K
76642 <1% 524 $67K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 441 $64K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 183 $63K
93325 <1% 697 $63K
97803 <1% 752 $59K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,893 $58K
36415 Collection of venous blood by venipuncture <1% 52,026 $56K
93970 <1% 446 $56K
97161 <1% 1,861 $55K
76830 Ultrasound, transvaginal <1% 835 $55K
76536 <1% 485 $53K
99232 Hospital visit by a doctor, follow-up day <1% 2,715 $51K
93971 <1% 748 $50K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 3,496 $48K
97802 <1% 788 $45K
72197 <1% 150 $45K
86900 <1% 3,810 $45K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 371 $45K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 119 $45K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 341 $44K
85027 <1% 13,191 $44K
93458 <1% 37 $43K
84443 Thyroid stimulating hormone (TSH) <1% 4,234 $42K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,498 $40K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,919 $39K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 285 $39K
77336 <1% 322 $37K
73610 <1% 1,316 $36K
97535 Self-care/home management training, each 15 minutes <1% 1,520 $35K
54150 <1% 789 $33K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,869 $32K
97165 <1% 843 $31K
97116 <1% 1,168 $30K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 421 $30K
12001 <1% 193 $30K
86780 <1% 1,536 $29K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,259 $29K
80061 Lipid panel <1% 2,556 $28K
94060 <1% 288 $27K
94010 <1% 604 $27K
76857 <1% 1,043 $26K
77067 Screening mammography, bilateral, including computer-aided detection <1% 883 $25K
77063 Screening digital breast tomosynthesis, bilateral <1% 498 $25K
12011 <1% 155 $24K
74018 <1% 1,130 $24K
93799 <1% 4,661 $23K
83036 Hemoglobin; glycosylated (A1C) <1% 2,053 $22K
87340 <1% 1,086 $22K
88307 <1% 177 $22K
74183 <1% 100 $21K
71275 Computed tomographic angiography, chest, with contrast material <1% 57 $20K
96112 <1% 72 $20K
73502 <1% 861 $20K
84439 <1% 1,483 $20K
82728 <1% 1,741 $20K
J1756 Injection, iron sucrose, 1 mg <1% 597 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 1,779 $19K
86803 <1% 995 $19K
95811 <1% 28 $19K
20610 <1% 149 $19K
90688 <1% 2,652 $19K
84702 <1% 1,477 $19K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 5,175 $18K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,354 $18K
73110 <1% 891 $18K
84484 <1% 9,613 $18K
83735 <1% 11,138 $18K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,213 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,158 $17K
73030 <1% 1,071 $17K
86762 <1% 486 $17K
73630 <1% 1,018 $17K
86901 <1% 3,813 $17K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 70 $17K
72100 <1% 740 $16K
73560 <1% 771 $16K
82962 <1% 11,182 $16K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,076 $15K
82607 <1% 1,111 $15K
86140 <1% 3,209 $15K
71045 Radiologic examination, chest; single view <1% 4,659 $15K
73590 <1% 684 $15K
73564 <1% 857 $15K
73130 <1% 836 $14K
70486 <1% 461 $14K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 320 $14K
80069 <1% 1,760 $14K
81001 <1% 16,388 $14K
70496 <1% 526 $13K
83540 <1% 1,908 $13K
90715 <1% 981 $13K
76801 <1% 519 $12K
90677 <1% 884 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,623 $12K
73700 <1% 93 $12K
72141 <1% 95 $12K
0124A <1% 400 $12K
99152 <1% 917 $11K
83550 <1% 1,887 $11K
90670 <1% 1,449 $10K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,154 $10K
90698 <1% 1,717 $10K
72131 <1% 173 $10K
85610 <1% 4,768 $10K
90651 <1% 568 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 594 $9K
0004A <1% 244 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 83 $8K
87481 <1% 1,142 $8K
62323 <1% 48 $8K
99213 Doctor's office visit, returning patient (routine) <1% 409 $8K
77300 <1% 18 $8K
A9270 Non-covered item or service <1% 3,068 $7K
83880 <1% 1,575 $7K
96368 <1% 376 $7K
82570 <1% 1,314 $7K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,752 $7K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 407 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 7,257 $7K
96376 <1% 3,059 $6K
91320 <1% 137 $6K
90480 <1% 392 $6K
71271 <1% 40 $6K
90832 Psychotherapy session, about 30 minutes <1% 47 $6K
73552 <1% 401 $6K
80076 <1% 540 $6K
90633 <1% 915 $6K
83655 <1% 530 $5K
87077 <1% 1,583 $5K
82950 <1% 343 $5K
83970 <1% 264 $5K
83690 <1% 5,078 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,384 $5K
77080 <1% 81 $5K
0071A <1% 170 $5K
0072A <1% 169 $5K
74019 <1% 687 $5K
84100 <1% 1,352 $4K
82784 <1% 386 $4K
0054A <1% 340 $4K
84153 <1% 347 $4K
77062 <1% 98 $4K
77065 Tomosynthesis, mammo <1% 266 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 68 $4K
90680 <1% 1,168 $4K
76882 <1% 41 $4K
73080 <1% 258 $4K
99221 <1% 256 $4K
73090 <1% 415 $4K
72170 <1% 733 $4K
77049 <1% 12 $4K
87505 <1% 33 $4K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 27 $4K
99153 Mod sedat endo service >5yrs <1% 434 $4K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,214 $4K
10060 <1% 22 $3K
90472 Immunization administration, each additional vaccine (list separately) <1% 2,102 $3K
72040 <1% 139 $3K
Q3014 Telehealth originating site facility fee <1% 120 $3K
90697 <1% 459 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 797 $3K
82746 <1% 536 $3K
96158 <1% 37 $3K
90658 <1% 464 $3K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 16 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 698 $3K
82330 <1% 2,604 $3K
76870 <1% 170 $3K
73060 <1% 223 $3K
J3490 Unclassified drugs <1% 285 $3K
90620 <1% 71 $3K
96160 <1% 16 $3K
90744 <1% 591 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 131 $3K
99214 Doctor's office visit, returning patient (more involved) <1% 69 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 522 $3K
72050 <1% 43 $3K
85018 <1% 2,736 $3K
99222 Initial hospital care, per day, moderate complexity <1% 77 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,319 $2K
85652 <1% 897 $2K
83020 <1% 119 $2K
99253 <1% 68 $2K
00840 <1% 380 $2K
90461 <1% 1,671 $2K
0003A <1% 56 $2K
84156 <1% 853 $2K
85730 <1% 1,956 $2K
83605 <1% 3,576 $2K
86923 <1% 90 $2K
87186 <1% 1,128 $2K
90716 <1% 332 $2K
82550 <1% 1,258 $2K
90619 <1% 278 $2K
82077 <1% 1,901 $2K
94729 <1% 57 $2K
82947 <1% 2,389 $2K
82533 <1% 197 $2K
82043 <1% 387 $2K
86870 <1% 38 $2K
99203 Doctor's office visit, new patient (routine) <1% 71 $2K
77061 <1% 45 $2K
87070 <1% 577 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 51 $2K
77066 Tomosynthesis, mammo <1% 184 $2K
86706 <1% 131 $2K
J2800 Injection, methocarbamol, up to 10 ml <1% 637 $2K
83615 <1% 559 $2K
90707 <1% 405 $2K
84403 <1% 102 $2K
J2469 Injection, palonosetron hcl, 25 mcg <1% 362 $1K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 72 $1K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 13 $1K
J1815 Injection, insulin, per 5 units <1% 131 $1K
76825 <1% 12 $1K
88341 <1% 16 $1K
90696 <1% 195 $1K
87040 <1% 1,407 $1K
85379 <1% 1,268 $1K
84550 <1% 344 $1K
80197 <1% 75 $1K
82565 <1% 119 $1K
81003 <1% 2,734 $1K
86364 <1% 102 $1K
85041 <1% 162 $1K
81025 <1% 5,860 $1K
87493 <1% 47 $1K
84132 <1% 2,743 $1K
0052A <1% 70 $1K
82435 <1% 2,134 $1K
82375 <1% 2,312 $1K
99244 Office or other outpatient consultation, moderate to high complexity <1% 25 $963.96
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,314 $930.50
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 83 $904.36
S9443 Lactation classes, non-physician provider, per session <1% 17 $886.17
83001 <1% 32 $881.40
85045 <1% 393 $866.95
82248 <1% 253 $862.99
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,421 $848.19
95012 <1% 16 $813.78
97162 <1% 16 $801.34
86038 <1% 48 $777.19
00731 <1% 224 $761.72
84145 <1% 229 $752.32
87205 <1% 558 $739.50
72110 <1% 19 $732.56
87522 Neg quan hep c or qual rna <1% 32 $709.02
86308 <1% 354 $692.67
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 97 $690.81
84703 <1% 627 $688.33
73140 <1% 144 $673.65
83050 <1% 2,324 $664.23
76827 <1% 12 $662.63
J1170 Injection, hydromorphone, up to 4 mg <1% 1,795 $651.53
90710 <1% 178 $633.85
88304 <1% 328 $630.12
99243 <1% 26 $591.05
90686 <1% 75 $589.54
84295 <1% 2,271 $582.78
0051A <1% 41 $574.30
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,547 $558.82
90662 <1% 77 $551.98
99239 Hospital discharge day management, more than 30 minutes <1% 18 $538.92
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,235 $524.22
87653 <1% 51 $499.03
99349 <1% 17 $479.02
C9290 Injection, bupivacaine liposome, 1 mg <1% 37 $475.96
0154A <1% 14 $462.84
72072 <1% 30 $449.25
C9113 Injection, pantoprazole sodium, per vial <1% 456 $444.79
93320 <1% 185 $432.24
86258 <1% 18 $422.67
73000 <1% 20 $419.93
0064A <1% 19 $419.02
86703 <1% 289 $413.45
84146 <1% 16 $395.42
84481 <1% 56 $389.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,802 $357.84
51798 <1% 112 $355.07
J1644 Injection, heparin sodium, per 1000 units <1% 2,183 $352.44
84460 <1% 70 $344.05
86480 <1% 14 $328.75
J0690 Injection, cefazolin sodium, 500 mg <1% 2,511 $325.28
84450 <1% 55 $319.88
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 15 $292.65
87486 <1% 68 $273.93
J2704 Injection, propofol, 10 mg <1% 4,745 $252.45
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 14 $251.77
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 396 $248.31
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,496 $230.07
J1650 Injection, enoxaparin sodium, 10 mg <1% 223 $220.87
83921 <1% 15 $216.81
73070 <1% 14 $213.28
86003 <1% 13 $201.21
87581 <1% 68 $193.73
86304 <1% 15 $189.19
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 14 $186.56
77091 <1% 15 $181.52
82150 <1% 81 $180.06
88342 <1% 100 $178.77
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,342 $170.88
J0360 Injection, hydralazine hcl, up to 20 mg <1% 509 $166.63
80143 <1% 159 $154.73
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,918 $150.04
82247 <1% 46 $133.25
C1769 Guide wire <1% 843 $126.94
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,792 $113.61
80179 <1% 120 $107.03
J2060 Injection, lorazepam, 2 mg <1% 799 $102.23
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,774 $100.70
J0780 Injection, prochlorperazine, up to 10 mg <1% 696 $97.58
85384 <1% 46 $92.60
C2625 Stent, non-coronary, temporary, with delivery system <1% 32 $87.88
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,084 $86.77
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 424 $86.45
J7030 Infusion, normal saline solution , 1000 cc <1% 663 $77.15
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 316 $74.55
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,981 $73.40
82378 <1% 13 $71.18
82010 <1% 154 $69.48
90685 <1% 12 $66.50
90474 <1% 145 $63.82
J1171 Injection, hydromorphone, 0.1 mg <1% 109 $61.91
J3480 Injection, potassium chloride, per 2 meq <1% 904 $59.05
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,844 $58.95
J1790 Injection, droperidol, up to 5 mg <1% 393 $58.41
81002 <1% 62 $57.68
91300 <1% 4,472 $56.37
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 14 $56.25
87088 <1% 47 $55.59
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,076 $52.96
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 689 $48.50
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 354 $43.01
87430 <1% 17 $36.83
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 403 $33.44
82803 <1% 38 $32.80
J3370 Injection, vancomycin hcl, 500 mg <1% 711 $32.60
J2470 Injection, pantoprazole sodium, 40 mg <1% 104 $21.44
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 52 $20.78
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,918 $18.91
88720 <1% 270 $9.97
J1596 Injection, glycopyrrolate, 0.1 mg <1% 419 $9.67
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 445 $8.00
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 296 $7.00
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 95 $4.40
J1940 Injection, furosemide, up to 20 mg <1% 80 $3.66
91307 <1% 411 $2.81
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 587 $2.00
91305 <1% 450 $1.73
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 188 $1.61
91312 <1% 303 $1.42
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 40 $1.05
J7050 Infusion, normal saline solution, 250 cc <1% 1,273 $0.65
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 43 $0.46
91308 <1% 47 $0.39
91315 <1% 14 $0.12
91306 <1% 19 $0.11
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 1,503 $0.00
96417 0% 282 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 386 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 89 $0.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 0% 70 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 13 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 809 $0.00
76377 0% 120 $0.00
94760 0% 2,102 $0.00
00142 0% 168 $0.00
A4648 Tissue marker, implantable, any type, each 0% 34 $0.00
G0008 Administration of influenza virus vaccine 0% 62 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 14 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.